OR
CLICK HERE TO REGISTER AT NO COST
SAVE 20% - 50% ON
Medical Supplies
Additional Information
Description
The MOUNJARO® (Tirzepatide)* Inj 2.5mg/.5ml prefilled pen serves as the initial once-weekly titration dose for adults with type 2 diabetes mellitus, introducing a novel first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that provides significant A1C reduction and body weight loss through synergistic enhancement of glucose-dependent insulin secretion, glucagon suppression, and slowed gastric emptying, addressing multiple facets of the disease beyond the capability of single GLP-1 receptor agonists.
You've just added this product to thecart: